TheProfitWatch

KNSA - Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
38.99 -0.18 (-0.46%) --- --- --- -0.04 (-0.1%) 0.99 (2.62%) --- -0.04 (-0.1%)

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
0.24
Diluted EPS:
0.23
Basic P/E:
161.7083
Diluted P/E:
168.7391
RSI(14) 1m:
10.0
VWAP:
38.83
RVol:
0.7156

Events

Period Kind Movement Occurred At

Related News